July – Newsweek, in partnership with The Leapfrog Group, recognized Applied Medical’s Alexis protectors and systems for the second year in a row in its Best Infection Prevention Products 2021 annual review.
October – Applied Medical launches the next advancement of the Voyant Intelligent Energy system with a new algorithm to enhance clinical performance. The Voyant system has the unique ability to accelerate learning through user experience. The system’s intelligence is embedded in the device key to store activation data from each vessel or tissue bundle sealed during the surgical procedure. Data extracted from surgeries is analyzed by Applied Medical to produce new algorithms to meet ever-changing healthcare needs. The newest algorithm offers multiple benefits to surgeons, including reliable hemostasis with average burst pressures greater than 3x systolic, faster sealing times, and an overall reduction in tissue adherence.
June – As a part of our commitment to rapidly respond to clinical needs, Applied Medical is pleased to introduce NP swabs for COVID-19 testing. Available in two 6” models with 70mm breakpoints, each sterile swab is designed, developed, and manufactured in-house at our Southern California headquarters. The swabs deliver clinical solutions to healthcare providers during these unprecedented times.
May – Newsweek, in partnership with The Leapfrog Group, published its first “Best Health Care” series. The article highlights some of the best infection prevention products, including Applied Medical’s Alexis wound protector-retractor.
May – In response to the rising demand for affordable hernia repair devices, Applied Medical is proud to introduce the Kii Dissecting Balloon access system for use in creating the surgical working space during totally extraperitoneal (TEP) surgery. Available in both round and oval configurations, the new devices provide a cost-beneficial alternative for surgeons focused on delivering the highest quality care to their patients for treatment of inguinal hernias.
March – A study published in the ANZ Journal of Surgery demonstrates that use of Applied Medical’s Alexis Orthopaedic protector, a medical device designed to isolate the superficial tissue layer from the surgeons’ gloves, instruments and retractors, significantly decreases the incidence of P. acnes infection in the surgical field by acting as a physical barrier.
July – New clinical evidence demonstrates the value of Applied Medical’s Alexis wound protector/retractor in pancreaticoduodenectomy (PD) procedures, also known as Whipple procedures. A study published in the Annals of Surgery showcases a 52 percent reduction in PD surgical site infection when the Alexis wound protector/retractor is used compared to cases that did not utilize a wound protector.
March – A meta-analysis study published in Surgical Endoscopy shows that wound protector use is associated with a statistically significant reduction in SSI in patients undergoing lower gastrointestinal surgery. The study further shows that there is a 63 percent decrease in SSI risk when using dual-ring wound protectors compared to using single-ring wound protectors.
October – Applied Medical, a global medical device company, has expanded its European operations with the opening of a new 20.000m2 manufacturing and R&D facility at its European headquarters in Amersfoort, Netherlands.
June – Applied Medical announces the completion of a 2.94 megawatt (DC) solar installation, consisting of rooftop arrays on eight separate buildings at its headquarters in Rancho Santa Margarita, Calif. and a local distribution center. Combined, they generate almost five million kilowatt hours of electricity annually. This latest investment in solar supports the commitment Applied Medical has made to its sustainability efforts.